LAMISIL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Lamisil, and what generic alternatives are available?
Lamisil is a drug marketed by Karo Hlthcare and Novartis and is included in eight NDAs.
The generic ingredient in LAMISIL is terbinafine. There are twenty-seven drug master file entries for this compound. Additional details are available on the terbinafine profile page.
Summary for LAMISIL
US Patents: | 0 |
Applicants: | 2 |
NDAs: | 8 |
Finished Product Suppliers / Packagers: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 91 |
Clinical Trials: | 19 |
Patent Applications: | 4,432 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for LAMISIL |
What excipients (inactive ingredients) are in LAMISIL? | LAMISIL excipients list |
DailyMed Link: | LAMISIL at DailyMed |
Recent Clinical Trials for LAMISIL
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Oregon Health and Science University | Early Phase 1 |
The Malassezia Foundation | Early Phase 1 |
Pak Emirates Military Hospital | Phase 3 |
Pharmacology for LAMISIL
Drug Class | Allylamine Antifungal |
Anatomical Therapeutic Chemical (ATC) Classes for LAMISIL
US Patents and Regulatory Information for LAMISIL
Expired US Patents for LAMISIL
International Patents for LAMISIL
See the table below for patents covering LAMISIL around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Hong Kong | 21588 | PROPENYLAMINES,PROCESSES FOR THEIR PRODUCTION,PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USE AS PHARMACEUTICALS | ⤷ Try a Trial |
Hungary | T62466 | ⤷ Try a Trial | |
Austria | 375063 | ⤷ Try a Trial | |
Spain | 8105694 | ⤷ Try a Trial | |
Austria | A602578 | ⤷ Try a Trial | |
Austria | A102392 | ⤷ Try a Trial | |
Japan | S63313753 | PROPENYLAMINES, MANUFACTURE, DRUG COMPOSITION AND USE AS MEDICINE | ⤷ Try a Trial |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for LAMISIL
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0024587 | 93C0136 | Belgium | ⤷ Try a Trial | PRODUCT NAME: TERBINAFINE (250 MG) SOUS FORME DE CHLORHYDRATE (281,25 MG); NAT. REG.: 616 S 201 F3 19911031; FIRST REG.: GB PL 0101/0304 19901003 |
0024587 | SPC/GB93/096 | United Kingdom | ⤷ Try a Trial | SPC/GB93/096, EXPIRES: 20050805 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |